✦ LIBER ✦

Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders

✍ Scribed by Gerassimos A. Pangalis; Marie-Christine Kyrtsonis; Flora N. Kontopidou; Theodoros P. Vassilakopoulos; Marina P. Siakantaris; Maria N. Dimopoulou; Christos Kittas; Maria K. Angelopoulou

Book ID: 114481320
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 65 KB
Volume: 30
Category: Article
ISSN: 0093-7754
DOI: 10.1053/sonc.2003.50046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differential Diagnosis of Waldenström's

Differential Diagnosis of Waldenström's Macroglobulinemia and Other B-Cell Disorders

✍ Pangalis, Gerassimos A.; Kyrtsonis, Maria-Christina; Kontopidou, Flora N.; Siaka 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 546 KB

Quantitative flow cytometry for the diff

Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders

✍ Giovanni D'Arena; Pellegrino Musto; Nicola Cascavilla; Matteo Dell'Olio; Nicola 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Waldenström’s macroglobulinemia is a bio

Waldenström’s macroglobulinemia is a biological syndrome which may occur during the evolution of different types of low grade B cell lymphoma

✍ Diebold, J; Molina, T; Tissier, F; le Tourneau, A; Audouin, J 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 60 KB

Immunophenotyping in the differential di

Immunophenotyping in the differential diagnosis of histologically low grade B cell lymphomas

✍ A.C. Wotherspoon; R.P. Hasserjian 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 294 KB

O28 Outcome of sibling reduced-intensity

O28 Outcome of sibling reduced-intensity conditioning allogeneic stem cell transplantations in low-grade B cell lymphoproliferative disorders

✍ M. Dávid; R. Desmond; E. Conneally; P. Browne; S. McCann; M. Ni Chonghaile; E. V 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB

for transplants are lymphomas, leukemias, multiple myeloma and solid malignancies. Children transplant center reports lower allogeneic than autologous peritransplant mortality (9.5% vs 12%), better overall survival allo vs autoSCT (67.63% vs 21.3%). Survival of children is significantly better with

A Phase I Dose-Finding Trial of Recombin

A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders

✍ Timmerman, J. M.; Byrd, J. C.; Andorsky, D. J.; Yamada, R. E.; Kramer, J.; Muthu 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 371 KB